ANI Pharmaceuticals | ANIP - Trade Debtors

Stock Price
79.12
Daily Change
-0.35 -0.44%
Monthly
5.76%
Yearly
19.86%
Q2 Forecast
71.98

ANI Pharmaceuticals reported $281.08M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
ANI Pharmaceuticals USD 281.08M 28.46M Dec/2025
Assertio Holdings USD 39.91M 2.7M Jun/2024
Aurora Cannabis CAD 48.26M 1.53M Dec/2025
Canopy Growth CAD 140.42M 113.56M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Omeros USD 8.08M 440K Jun/2024
Perrigo USD 612.8M 31.6M Dec/2025
Sun Pharmaceuticals INR 157.04B 26.1B Sep/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025